N-terminal rather than full-length osteopontin or its C-terminal fragment is associated with carotid-plaque inflammation in hypertensive patients

American Journal of Hypertension

Volumn 26, Issue 3, 2013, Pages 326-333

  Wolak, Talya ^a   Sion Vardi, Neta ^a   Novack, Victor ^a   Greenberg, Georg ^a   Szendro, Gabriel ^a   Tarnovscki, Tanya ^b   Nov, Ori ^b   Shelef, Ilan ^a   Paran, Esther ^a   Rudich, Assaf ^b  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b Department of Clinical Biochemistry and Pharmacology   (Israel)

Author keywords

blood pressure; carotid plaque; hypertension; inflammation; OPN N; osteopopontin

Indexed keywords

CHLORDANE; MACROPHAGE ELASTASE; OSTEOPONTIN;

AGED; ARTICLE; CAROTID ATHEROSCLEROSIS; CAROTID ENDARTERECTOMY; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; HISTOLOGY; HUMAN; HYPERTENSION; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; WESTERN BLOTTING;

AGED; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BIOLOGICAL MARKERS; ENDARTERECTOMY, CAROTID; FEMALE; HUMANS; HYPERTENSION; INFLAMMATION; MALE; MIDDLE AGED; OSTEOPONTIN; PEPTIDE FRAGMENTS; PLAQUE, ATHEROSCLEROTIC;

EID: 84876582298     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1093/ajh/hps043     Document Type: Article

References (22)

1. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003;21:1011-1053.
2. Whitworth JA. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003;21:1983-1992. (Pubitemid 38296854)
3. Handberg A, Skjelland M, Michelsen AE, Sagen EL, Krohg-Sorensen K, Russell D, Dahl A, Ueland T, Oie E, Aukrust P, Halvorsen B. Soluble CD36 in plasma is increased in patients with symptomatic atherosclerotic carotid plaques and is related to plaque instability. Stroke 2008;39:3092-3095.
4. Vicenzini E, Ricciardi MC, Puccinelli F, Altieri M, Vanacore N, Di Piero V, Lenzi GL. Sonographic carotid plaque morphologic characteristics and vascular risk factors: results from a population study. J Ultrasound Med 2008;27:1313-1319.
5. Kadoglou NP, Gerasimidis T, Golemati S, Kapelouzou A, Karayannacos PE, Liapis CD. The relationship between serum levels of vascular calcification inhibitors and carotid plaque vulnerability. J Vasc Surg 2008;47:55-62.
6. Golledge J, McCann M, Mangan S, Lam A, Karan M. Osteoprotegerin and osteopontin are expressed at high concentrations within symptomatic carotid atherosclerosis. Stroke 2004;35:1636-1641. (Pubitemid 38823639)
7. Myers DL, Harmon KJ, Lindner V, Liaw L. Alterations of arterial physiology in osteopontin-null mice. Arterioscler Thromb Vasc Biol 2003;23:1021-1028. (Pubitemid 36713555)
8. Chiba S, Okamoto H, Kon S, Kimura C, Murakami M, Inobe M, Matsui Y, Sugawara T, Shimizu T, Uede T, Kitabatake A. Development of atherosclerosis in osteopontin transgenic mice. Heart Vessels 2002;16:111-1117.
9. Butler WT. The nature and significance of osteopontin. Connect Tissue Res 1989;23:123-136.
10. Denhardt DT, Noda M. Osteopontin expression and function: role in bone remodeling. J Cell Biochem Suppl 1998;30-31:92-102. (Pubitemid 29028730)
11. Denhardt DT, Noda M, O'Regan AW, Pavlin D, Berman JS. Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. J Clin Invest 2001;107:1055-1061. (Pubitemid 32422899)
12. Senger DR, Perruzzi CA, Papadopoulos-Sergiou A, Van de Water L. Adhesive properties of osteopontin: regulation by a naturally occurring thrombin-cleavage in close proximity to the GRGDS cell-binding domain. Mol Biol Cell 1994;5:565-574. (Pubitemid 24183445)
13. Myles T, Leung LL. Thrombin hydrolysis of human osteopontin is dependent on thrombin anion-binding exosites. J Biol Chem 2008;283:17789-17796.
14. Pelisek J, Hahntow IN, Eckstein HH, Ockert S, Reeps C, Heider P, Luppa PB, Frank H. Impact of chronic kidney disease on carotid plaque vulnerability. J Vasc Surg 2011;54:1643-1649.
15. Bashan N, Dorfman K, Tarnovscki T, Harman-Boehm I, Liberty IF, Bluher M, Ovadia S, Maymon-Zilberstein T, Potashnik R, Stumvoll M, Avinoach E, Rudich A. Mitogen-activated protein kinases, inhibitory-kappaB kinase, and insulin signaling in human 328 omental versus subcutaneous adipose tissue in obesity. Endocrinology 2007;148: 2955-2962. (Pubitemid 46984790)
16. Kovsan J, Ben-Romano R, Souza SC, Greenberg AS, Rudich A. Regulation of 330adipocyte lipolysis by degradation of the perilipin protein: nelfinavir enhances lysosome-mediated perilipin proteolysis. J Biol Chem 2007;282:21704-21711. (Pubitemid 47195753)
17. Bruemmer D, Collins AR, Noh G, Wang W, Territo M, Arias-Magallona S, Fishbein MC, Blaschke F, Kintscher U, Graf K, Law RE, Hsueh WA. Angiotensin II-accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin deficient mice. J Clin Invest 2003;112:1318-1331. (Pubitemid 38057686)
18. Kurata M, Okura T, Watanabe S, Fukuoka T, Higaki J. Osteopontin and carotid atherosclerosis in patients with essential hypertension. Clin Sci (Lond) 2006;111:319-324. (Pubitemid 44690190)
19. de Kleijn DP, Moll FL, Hellings WE, Ozsarlak-Sozer G, de Bruin P, Doevendans PA, Vink A, Catanzariti LM, Schoneveld AH, Algra A, Daemen MJ, Biessen EA, de Jager W, Zhang H, de Vries JP, Falk E, Lim SK, van der Spek PJ, Sze SK, Pasterkamp G. Local atherosclerotic plaques are a source of prognostic biomarkers for adverse cardiovascular events. Arterioscler Thromb Vasc Biol 2010;30:612-619.
20. Lai CF, Seshadri V, Huang K, Shao JS, Cai J, Vattikuti R, Schumacher A, Loewy AP, Denhardt DT, Rittling SR, Towler DA. An osteopontin-NADPH oxidase signaling cascade promotes pro-matrix metalloproteinase 9 activation in aortic mesenchymal cells. Circ Res 2006;98:1479-1489. (Pubitemid 44297070)
21. Gao YA, Agnihotri R, Vary CP, Liaw L. Expression and characterization of recombinant osteopontin peptides representing matrix metalloproteinase proteolytic fragments. Matrix Biol 2004;23:457-466. (Pubitemid 39576660)
22. Scatena M, Liaw L, Giachelli CM. Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler Thromb Vasc Biol 2007;27:2302-2309. (Pubitemid 350203943)